Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sela2, Inc., primarily known by its trade name Skila, was a global technology and services company providing knowledge-driven management solutions for the life sciences and pharmaceutical industries. Founded in 1994 and based in Morris Plains, New Jersey, the company specialized in software and managed services for product launch management and Key Opinion Leader (KOL) engagement. Its core technology, Intelligration®, was designed to integrate disparate data sources and internal systems to provide actionable insights for global marketing and medical affairs teams. Sela2 was acquired by BelHealth Investment Partners in 2011 and subsequently merged into SkilaMederi and later Qforma, which was eventually acquired by Veeva Systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sela2.